Upcoming Online Events

Stay up to date! In this section we will inform you about upcoming online events that you should not miss!

If you know about any upcoming online event that you consider worth announcing here, please let us know by sending us an email.

Webinar

COVID-19 and Blood Cancer CLL treatment – a changing landscape

This UK CLL patients webinar is hosted by Leukaemia Care UK and will give you the opportunity to ask the experts your questions on chronic lymphocytic leukaemia (CLL) and its current and future treatments. We’ll be joined by experts Professor Anna Schuh, consultant haematologist, Chair of the NCRi CLL clinical research group and Director of Molecular Diagnostics at Oxford University; Dr David Allsup, Senior Lecturer in Haematology and CLL lead at Queens Centre for Oncology and Haematology at Castle Hill Hospital, Hull; and Helen Knight, CLL Nurse Specialist at Nottingham University Hospital.

Date and Time:
Monday, June 29, 2020
11:00 PM (London)

For more information and to register your attendance via Zoom, please click here!

Webinar

COVID-19: Implications for Patients With CLL

Live and interactive, CME-certified Webinar to gain expert opinion on the ongoing developments in providing optimal care for patients with CLL during COVID-19, and evolving research into countering COVID-19–associated inflammatory cytokine production.

Date and Time:
Monday, July 6, 2020
7:00 PM ET / 4:00 PM PT / 01:00 am CET on July 7!

Faculty presenter:
Nicole Lamanna, MD
Associate Attending
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York – Presbyterian/Columbia University Medical Center
New York, New York

Agenda

  • COVID-19
    • Virology, immunology, and pathogenesis
    • Natural history and clinical presentation
    • Screening and diagnosis
    • Current medical management
  • Clinic/center preparedness
  • Management of the patient with CLL in the era of COVID-19
    • Active cancer treatment
    • Survivorship care
    • Telemedicine utilizations
  • Conduct of clinical trials in CLL
  • Clinical trials to reduce the production of inflammatory cytokines in patients with severe respiratory symptoms from COVID-19

For more information and to register your attendance, please click here!

Please note that login details will be emailed to registered attendees before the start of the presentation. Attendees will be able to submit questions in real time and interact with polling questions.

© 2020 – CLL Advocates Network
Website handcrafted by Lawrence Mouawad